dateRange

Countdown to the Conference!

122

Days

13

Hours

10

Minutes

ASLMS Policy on Mechanisim to Identify and Resolve Conflict of Interest

The American Society for Laser Medicine and Surgery is The American Society for Laser Medicine and Surgery is accredited by the Accreditation Council for Continuing Medical Education (ACCME). As such, we have made the choice to meet the ACCME’s criteria for our practice of continuing medical education. Our accreditation is important to us. We look forward to working together to provide CME at the highest standard.

The ASLMS has implemented a process where everyone who is in a position to control the content of an educational activity must disclose to us all financial relationships with any commercial interest they and their spouse/partner may have received within the last 12 months. Should it be determined that a conflict of interest exists as a result of a financial relationship, it will need to be resolved prior to their involvement. In order to do this, all individuals who are in a position to control the content must complete a disclosure form. If any conflict develops between the time the disclosure form is completed and the educational activity, the individual must notify the ASLMS in writing and disclose the additional conflict of interest. Individuals, who refuse to disclose all financial relationships, will be disqualified from being a part of the planning and implementation of the CME activity.

Process of Identifying and Resolving Conflict of Interest

Annual Conference (Program Chair, Section Chairs, Speakers)

  1. The President selects the Program Chair.
  2. A Disclosure of Conflict of Interest “COI” form is completed by the Program Chair(s).
  3. If a Program Chair refuses to disclose all financial relationships, he/she will be disqualified from participating in the program.
  4. The CME Director reviews the Program Chair disclosure form and completes an Acknowledgement of Disclosure Review form. If it appears that a Program Chair has a COI as a result of a financial relationship, it will need to be resolved in order for the person to serve as Program Chair. If necessary, determination will be made by the CME Director under the guidance of the Board of Directors whether the proposed Program Chair can participate in the program.
  5. The Program Chair(s) select Section Chairs.
  6. A COI form is completed by each of the Section Chairs.
  7. If a Section Chair refuses to disclose all financial relationships, he/she will be disqualified from participating in the program.
  8. The CME Director reviews the Section Chair(s) COI forms and completes an Acknowledgement of Disclosure Review form. If it appears that a Section Chair has a COI as a result of a financial relationship, it will need to be resolved in order for the person to serve as Section Chair. If necessary, determination will be made by the Program Chair and CME Director under the guidance of the Board of Directors whether the proposed Section Chair can participate in the program.
  9. The Speakers complete the online disclosure form. The Section Chairs review the abstract and Speaker disclosure and complete an Acknowledgement of Disclosure Review form. If it appears that a Speaker has a COI as a result of a financial relationship, it will need to be resolved prior to the activity. If necessary, the Section Chair, Program Chair and CME Director,under the guidance of the Board of Directors, will make the determination whether the proposed Speaker can participate in the program.
  10. If any conflict develops between the time the disclosure form is completed and the educational activity, the individual must notify the ASLMS in writing and disclose the additional conflict of interest.
  11. The Section Chair and Speaker disclosure information is posted online, provided to attendees via electronic link, included as part of the preliminary (online only) and final programs (online and print copy at conference) and published in the journal.
  12. At the Annual Conference:
    1. Each Section Chair is provided with a checklist of Speakers who are required to disclose COI. The Section Chair is instructed to remind the Speaker to verbally disclose COI prior to their presentation, sign off on the checklist provided, and return the form to the ASLMS.
    2. In addition to a COI statement being posted online, provided via electronic link, and printed in program materials, a COI slide will be prepared by the ASLMS Central Office based on the information provided on the completed disclosure form. The slide will be inserted before each presentation on the Central Server and will include any proprietary interest in any drugs, instruments, or devices discussed in the presentation and/or any compensation received. Similarly, a slide will be shown to disclose the fact that the presentation content includes off-label uses of drugs or devices.
    3. If a Speaker discloses a COI in writing, but does not verbally disclose prior to his/her presentation, the Section Chair will remind the Speaker at the end of the presentation to disclose the COI
    4. If a Speaker does not pre-disclose in writing or verbally, but it becomes apparent that a COI exists, the Section Chair, Program Chair, CME Director and/or Board Member will notify the audience and the speaker of the perceived COI. The speaker will be warned that further failures to comply with policy will result in the speaker’s inability to participate in CME related activities of ASLMS in the future. (The Board of Directors may, at its discretion, impose other sanctions it feels are appropriate).
    5. Board members are provided with audit forms and asked to verify if Speakers disclose COI.
    6. Attendees complete evaluation forms and are asked to comment about proper COI disclosure. Evaluation forms are reviewed by the CME Director, Program Chair(s) and Section Chairs after which appropriate corrective action is taken.

Courses (Directors/Faculty)

  1. The Program Chair(s) select Course Directors.
  2. A Disclosure of Conflict of Interest “COI” form is completed by all Course Directors.
  3. If a Course Director refuses to disclose all financial relationships, he/she will be disqualified from participating in the program.
  4. The CME Director reviews the Course Director disclosure forms. The CME Director completes an Acknowledgement of Disclosure Review form. If it appears that a Course Director has a COI as a result of a financial relationship, it will need to be resolved in order for the person to serve as Course Director. If necessary, determination will be made by the Program Chair(s) and CME Director under the guidance of the Board of Directors if a proposed Course Director can participate in the program.
  5. The Course Director(s) select Faculty.
  6. The COI forms are completed by all Faculty
  7. If a Faculty Member refuses to disclose all financial relationships, he/she will be disqualified from participating in the program.
  8. The Course Director(s) and CME Director review the faculty disclosure forms. Course Director(s) complete an Acknowledgment of Disclosure Review form. If it appears that a Faculty Member has a COI as a result of a financial relationship, it will need to be resolved in order for the person to serve as a Faculty Member. If necessary, determination will be made by the Course Director(s), Program Chair(s), and CME Director under the guidance of the Board of Directors whether the proposed Faculty Member can participate in the program.
  9. If any conflict develops between the time the disclosure form is completed and the educational activity, the individual must notify the ASLMS in writing and disclose the additional conflict of interest.
  10. Disclosure information is posted online, provided to attendees via electronic link, and printed in the final program.
  11. At the conference:
    1. The Course Director(s) are provided with a checklist of Faculty Members who are required to disclose COI. The Course Director(s) are instructed to remind the Faculty to verbally disclose COI prior to their presentation, sign off on the checklist provided, and return the form to the ASLMS.
    2. In addition to a COI statement being printed in program materials, a COI slide will be prepared by the ASLMS Central Office based on the information provided on the completed disclosure form. The slide will be inserted before each presentation on the Central Server and will include any proprietary interest in any drugs, instruments, or devices discussed in the presentation and/or any compensation received. Similarly, a slide will be shown to disclose the fact that the presentation content includes off-label uses of drugs or devices.
    3. If a Faculty Member discloses a COI in writing, but does not verbally disclose prior to his/her presentation, the Course Director will remind Faculty at the end of the presentation to disclose COI.
    4. If a Faculty Member does not pre-disclose in writing or verbally, but it becomes apparent that a COI exists, the Course Director, Program Chair, CME Director and/or Board Member will notify the audience and the speaker of the perceived COI. The speaker will be warned that further failures to comply with policy will result in the speaker’s inability to participate in CME related activities of ASLMS in the future. (The Board of Directors may, at its discretion, impose other sanctions it feels are appropriate).
    5. Board members are provided with audit forms and asked to verify if Faculty discloses COI.
    6. Attendees complete evaluation forms and are asked to comment about proper COI disclosure. Evaluation forms are reviewed by the CME Director, Program Chair(s) and Course Directors after which appropriate corrective action is taken.

Board of Directors, Members, Officers, Candidates for Office or Committees

In order for the Society to further the purpose for which it is organized and to maintain its reputation for excellence, it is important that Society decisions and actions not be influenced unduly by any special interests or individual members. The Society depends upon its members to shape its policies and the actions of organization policy makers must not be inappropriately affected by outside influences. Accordingly, the Board of Directors of the Society has adopted a formal system for disclosure of interests. Society Board of Directors members, officers, candidates for officer positions and committee members must complete and submit a Disclosure of Interest Statement.

  1. Members of the ASLMS Board of Directors are required to complete the Disclosure of Interest Statement, annually. Copies of the completed disclosure forms will be included in each Board agenda, posted on the ASLMS website, and available at the ASLMS Central Office upon request.
  2. The Disclosure of interests shall include personal interests, interests as director, officer, member, stockholder, shareholder, partner, manager, academic mentor, consultant, employee, researcher, grantee, lobbyist, trustee or beneficiary of any concern and having an immediate family member who holds such an interest in any concern.
  3. The disclosure shall list “concerns” which include any corporation, association, joint venture, trust, partnership, limited liability entity, firm, institution, governmental body, endeavor, other entity other than the Society or person.
  4. In addition to completing the Disclosure of Interest Statement the discloser has an obligation to advise the Society of any interest of the discloser that is or potentially is in conflict with any interest of the Society as the discloser becomes aware of the conflict of interest or potential conflict of interest.
  5. The discloser acknowledges that as a director, officer, candidate for office or committee member of the American Society for Laser Medicine and Surgery, Inc., he/she occupies or seeks a position of trust with a fiduciary duty to act at all times in good faith and with loyalty to the Society.
  6. The discloser further acknowledges having received, read and understood the Society’s Disclosure of Interest Policy, and that he/she agrees to comply with it.
  7. The discloser certifies that, all of the interests as defined in the Policy have been disclosed to the best of his/her knowledge.
  8. The Secretary of the Society is charged with the responsibility to monitor potential conflict of interest and bring it to the attention of the Board.
  9. All Board Members are expected to verbally disclose conflicts of interest with any pertinent item on the agenda and recuse themselves from discussion and voting, including additional topics that may arise.
Approved by the Board of Directors, November 10, 2015

The American Society for Laser Medicine and Surgery is the world’s largest scientific organization dedicated to promoting research, education and high standards of clinical care in the field of medical laser applications. It provides a forum for the exchange of scientific information and participation in communicating the latest developments in laser medicine and surgery to clinicians, research investigators, government and regulatory agencies, and the public.

Connect with ASLMS!